Keyphrases
4-hydroxynonenal (4-HNE)
35%
5′-untranslated Region (5′-UTR)
34%
Advanced Glycation End Products
32%
Alcoholic Liver Disease
45%
Aphthous Stomatitis
32%
Binge Drinking
32%
Colonic Cancer
32%
Confidence Interval
53%
Cytochrome P450 2E1 (CYP2E1)
33%
Diabetic Dyslipidemia
32%
Ethanol
85%
Ethanol Intake
34%
Functional Dyspepsia
32%
Gastroduodenal Diseases
32%
Genetic Polymorphism
96%
GGsTop
53%
Glutamyl Transpeptidase
36%
Hepatic Ischemia-reperfusion Injury
64%
Hepatitis C Virus
58%
Hepatocellular Carcinoma
100%
High Mobility Group Box 1 (HMGB1)
39%
IL-17F
32%
Image Fusion System
32%
Interleukin-17 (IL-17)
64%
Interleukin-6
64%
Irsogladine Maleate
32%
Ischemia-reperfusion Injury
32%
Japan
33%
Limy Bile
32%
Liver
35%
Meta-analysis
48%
MicroRNA-325
32%
Necrosis
44%
NF1 Gene
32%
Non-alcoholic Fatty Liver Disease (NAFLD)
37%
Nonalcoholic Steatohepatitis
32%
Obesity
40%
Odds Ratio
60%
Oxidative Stress
32%
Pancreatic Fluid Collections
64%
Polymorphism
50%
Pre-microRNA
64%
Radiofrequency Ablation
64%
Recurrent Aphthous Stomatitis
32%
Risk Factors
33%
Rs2275913
45%
Simple Steatosis
32%
SLC6A4
32%
Therapeutic Effect
38%
Walled-off
33%
Pharmacology, Toxicology and Pharmaceutical Science
1,1 Dimethylhydrazine
32%
4 Hydroxynonenal
31%
Acetylsalicylic Acid
10%
Advanced Glycation End Product
32%
Adverse Event
26%
Alanine Aminotransferase
10%
Alcohol Liver Disease
49%
Alcoholic Fatty Liver
38%
Aphthous Stomatitis
32%
Aspartate Aminotransferase
10%
Biological Marker
32%
Chronic Hepatitis
32%
Colon Carcinoma
32%
Cytochrome
30%
Delirium
32%
Diabetes Mellitus
32%
Duodenum Disease
32%
Dyslipidemia
32%
Ethanol
56%
Fatty Liver
55%
Fibrosis
30%
Gamma Glutamyltransferase
86%
Hepatitis C
32%
Hepatitis C Virus
42%
Interleukin 17
32%
Interleukin 6
32%
Irsogladine Maleate
32%
Ischemia
77%
Jejunum Ulcer
32%
Liver Cell Carcinoma
35%
Liver Fibrosis
32%
Liver Ischemia
64%
Liver Necrosis
11%
Neoplasm
36%
Non-Steroidal Anti-Inflammatory Drug
10%
Nonalcoholic Fatty Liver
64%
Normal Human
18%
Opiate
10%
Osteopontin
32%
Otsuka Long Evans Tokushima Fatty Rat
35%
Pancreas Cancer
32%
Peginterferon
32%
Pharmacotherapy
10%
Recombinant Thrombomodulin
32%
Reperfusion Injury
64%
Ribavirin
32%
Steatosis
37%
Therapeutic Effect
35%
Tissue Injury
32%
Tumor Necrosis Factor
10%
Medicine and Dentistry
4 Hydroxynonenal
26%
Acute Pancreatitis
18%
Advanced Glycation End-Product
32%
Adverse Event
22%
Alcohol
35%
Alcohol Consumption
32%
Alcohol Liver Disease
49%
Alcoholic Fatty Liver
35%
Balloon Dilatation
32%
Celiac Plexus
32%
Chronic Hepatitis
32%
Common Bile Duct
27%
Common Bile Duct Stone
21%
COVID-19
16%
Cytochrome
21%
Delirium
32%
Diabetes Mellitus
32%
Dyslipidemia
32%
Echography
32%
Endoscopic Retrograde Cholangiopancreatography
21%
Endoscopic Ultrasound
73%
Fatty Liver
32%
Fine-Needle Aspiration
16%
Gamma-Glutamyl Transpeptidase
35%
Gastrectomy
17%
Hepatocellular Carcinoma
64%
Hepatocyte
16%
Immunoglobulin G4 Related Disease
16%
Infection
18%
Interleukin 6
32%
Ischemia
32%
Limy Bile
32%
Mesothelioma
32%
Meta-Analysis
16%
Necrosis
74%
Neoplasm
21%
Nonalcoholic Fatty Liver
64%
Obstructive Jaundice
32%
Odds Ratio
33%
Oxidative Stress
32%
Pancreas Cancer
32%
Pancreas Tumor
32%
Radiofrequency Ablation
64%
Randomized Controlled Trial
19%
Roux-en-Y
16%
Steatosis
37%
Systematic Review
16%
Therapy Effect
34%
Thrombocytosis
32%
Tissue Injury
32%